ALKS 35.32 (-0.51%)
IE00B56GVS15BiotechnologyBiotechnology

Alkermes (ALKS) Stock Highlights

35.32 | -0.51%
2025-02-22 02:19:05
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Statistics

Range Today
35.09 35.79
Volume Today 975.23K
Range 1 Year
22.9 36.45
Volume 1 Year 452.56M
Range 3 Year
21.75 36.45
Volume 3 Year 1.28B
Range 10 Year
11.98 80.71
Volume 10 Year 3.41B

Highlights

Market Capitalization 5.74B (mid)
Floating Shares 154.08M
Current Price 35.32
Price To Earnings 16.27
Price To Revenue 3.27
Price To Book 3.91
Earnings Per Share 2.2
Payout Ratio 0%

Performance

Latest -0.51%
1 Month +18.48%
3 Months +25.56%
6 Months +24.76%
1 Year +16.99%
3 Years +43.29%
5 Years +74.16%
10 Years -51.99%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.